After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA
In Brief: Comis Named ECOG Chairman; Long Joins Capitol Associates; Chabner Day In Shelbyville
Advisors’ Report On Intramural Program To Recommend Restructuring
Russian-American Breast Cancer Meeting Canceled
Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon
NCI, EORTC Offer Support For Russian Cancer Researchers
Public Forum On NRSA Tuition Policies
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community
